Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae.

Literature DB >> 12604549

Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae.

C Betriu¹, E Culebras, M Gómez, I Rodríguez-Avial, B A Sánchez, M C Agreda, J J Picazo.

Abstract

The rates of resistance to erythromycin and clindamycin among Streptococcus agalactiae strains isolated in our hospital increased from 4.2 and 0.8% in 1993 to 17.4 and 12.1%, respectively, in 2001. Erythromycin resistance was mainly due to the presence of an Erm(B) methylase, while the M phenotype was detected in 3.8% of the strains. Telithromycin was very active against erythromycin-resistant strains, irrespective of their mechanisms of macrolide resistance.

Entities: Chemical Species

Mesh：

Substances：

Year: 2003 PMID： 12604549 PMCID： PMC149330 DOI： 10.1128/AAC.47.3.1112-1114.2003

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

20 in total

1. Emerging erythromycin resistance among group B streptococci in Korea.

Authors: Y Uh; I H Jang; G Y Hwang; K J Yoon; W Song
Journal: Eur J Clin Microbiol Infect Dis Date: 2001-01 Impact factor: 3.267

2. Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study.

Authors: D De Mouy; J D Cavallo; R Leclercq; R Fabre
Journal: Antimicrob Agents Chemother Date: 2001-08 Impact factor: 5.191

3. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.

Authors: P R Hsueh; L J Teng; L N Lee; S W Ho; P C Yang; K T Luh
Journal: Antimicrob Agents Chemother Date: 2001-11 Impact factor: 5.191

4. Serotyping and antimicrobial susceptibility of group B Streptococcus over an eight-year period in southern Taiwan.

Authors: W C Ko; H C Lee; L R Wang; C T Lee; A J Liu; J J Wu
Journal: Eur J Clin Microbiol Infect Dis Date: 2001-05 Impact factor: 3.267

5. Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci.

Authors: A L Barry; P C Fuchs; S D Brown
Journal: Eur J Clin Microbiol Infect Dis Date: 2001-07 Impact factor: 3.267

6. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.

Authors: F Y Lin; P H Azimi; L E Weisman; J B Philips; J Regan; P Clark; G G Rhoads; J Clemens; J Troendle; E Pratt; R A Brenner; V Gill
Journal: Clin Infect Dis Date: 2000-07-24 Impact factor: 9.079

7. Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae.

Authors: Esther Culebras; Iciar Rodriguez-Avial; Carmen Betriu; Montserrat Redondo; Juan J Picazo
Journal: Antimicrob Agents Chemother Date: 2002-05 Impact factor: 5.191

8. Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.

Authors: D R Murdoch; L B Reller
Journal: Antimicrob Agents Chemother Date: 2001-12 Impact factor: 5.191

9. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.

Authors: J C de Azavedo; M McGavin; C Duncan; D E Low; A McGeer
Journal: Antimicrob Agents Chemother Date: 2001-12 Impact factor: 5.191

10. Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere.

Authors: J I Andrews; D J Diekema; S K Hunter; P R Rhomberg; M A Pfaller; R N Jones; G V Doern
Journal: Am J Obstet Gynecol Date: 2000-10 Impact factor: 8.661

26 in total

1. Prevalence of vancomycin-resistant enterococcus in prenatal screening cultures.

Authors: Melissa B Miller; Sonia L Allen; Mary Ellen Mangum; Anastassia Doutova; Peter H Gilligan
Journal: J Clin Microbiol Date: 2004-02 Impact factor: 5.948

2. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.

Authors: Young Uh; In Ho Jang; Gyu Yel Hwang; Mi Kyung Lee; Kap Jun Yoon; Hyo Youl Kim
Journal: Antimicrob Agents Chemother Date: 2004-07 Impact factor: 5.191

3. Prenatal culture-based screening of Streptococcus agalactiae colonisation: resistance against erythromycin and clindamycin.

Authors: V Lavergne; M Laverdière; A Duchesne; C Béliveau; J Delorme; A Di Zazzo; A C Labbé
Journal: Eur J Clin Microbiol Infect Dis Date: 2006-08 Impact factor: 3.267

10. Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France.

Authors: A Bergal; L Loucif; D E Benouareth; A A Bentorki; C Abat; J-M Rolain
Journal: Eur J Clin Microbiol Infect Dis Date: 2015-09-28 Impact factor: 3.267